Literature DB >> 31931174

Health benefits of fucoxanthin in the prevention of chronic diseases.

Minkyung Bae1, Mi-Bo Kim1, Young-Ki Park1, Ji-Young Lee2.   

Abstract

Fucoxanthin is a xanthophyll carotenoid abundant in macroalgae, such as brown seaweeds. When fucoxanthin is consumed, it can be esterified or hydrolyzed to fucoxanthinol in the gastrointestinal tract and further converted into amarouciaxanthin A in the liver. It has a unique chemical structure that confers its biological effects. Fucoxanthin has a strong antioxidant capacity by scavenging singlet molecular oxygen and free radicals. Also, it exerts an anti-inflammatory effect. Studies have demonstrated potential health benefits of fucoxanthin for the prevention of chronic diseases, such as cancer, obesity, diabetes mellitus, and liver disease. Animal studies have shown that fucoxanthin supplementation has no adverse effects. However, investigation of the safety of fucoxanthin consumption in humans is lacking. Clinical trials are required to assess the safety of fucoxanthin in conjunction with the study of mechanisms by which fucoxanthin exhibits its health benefits. This review focuses on current knowledge of metabolism and functions of fucoxanthin with its potential health benefits. This article is part of a Special Issue entitled Carotenoids recent advances in cell and molecular biology edited by Johannes von Lintig and Loredana Quadro.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anti-inflammation; Antioxidant; Brown seaweed; Carotenoid; Fucoxanthin

Mesh:

Substances:

Year:  2020        PMID: 31931174     DOI: 10.1016/j.bbalip.2020.158618

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Cell Biol Lipids        ISSN: 1388-1981            Impact factor:   4.698


  19 in total

Review 1.  Fucoxanthin Is a Potential Therapeutic Agent for the Treatment of Breast Cancer.

Authors:  Tsz-Ying Lau; Hiu-Yee Kwan
Journal:  Mar Drugs       Date:  2022-05-30       Impact factor: 6.085

Review 2.  Microalgae: Bioactive Composition, Health Benefits, Safety and Prospects as Potential High-Value Ingredients for the Functional Food Industry.

Authors:  Josephine Ampofo; Lord Abbey
Journal:  Foods       Date:  2022-06-14

3.  Phloroglucinol Promotes Fucoxanthin Synthesis by Activating the cis-Zeatin and Brassinolide Pathways in Thalassiosira pseudonana.

Authors:  Yan Liu; Yixuan Li; Hejing Zhao; Bilu Zhu; Jilin Xu; Feng Xu; Shixia Liu; Xiaohui Li; Chengxu Zhou
Journal:  Appl Environ Microbiol       Date:  2022-02-02       Impact factor: 5.005

Review 4.  Properties of Carotenoids in Fish Fitness: A Review.

Authors:  Toshiki Nakano; Geert Wiegertjes
Journal:  Mar Drugs       Date:  2020-11-19       Impact factor: 5.118

Review 5.  Pharmacokinetics of Marine-Derived Drugs.

Authors:  Alexander N Shikov; Elena V Flisyuk; Ekaterina D Obluchinskaya; Olga N Pozharitskaya
Journal:  Mar Drugs       Date:  2020-11-09       Impact factor: 5.118

Review 6.  Epigenetic Regulation of NRF2/KEAP1 by Phytochemicals.

Authors:  Shamee Bhattacharjee; Roderick H Dashwood
Journal:  Antioxidants (Basel)       Date:  2020-09-14

7.  Isolation and Purification of Fucoxanthin from Brown Seaweed Sargassum horneri Using Open ODS Column Chromatography and Ethanol Precipitation.

Authors:  Yuemei Ye; Jingwen Sun; Liting Wang; Junwang Zhu; Wei Cui; Hongyan Hou; Jinrong Zhang; Chengxu Zhou; Xiaojun Yan
Journal:  Molecules       Date:  2021-06-22       Impact factor: 4.411

8.  Fucoxanthin Ameliorates Oxidative Stress and Airway Inflammation in Tracheal Epithelial Cells and Asthmatic Mice.

Authors:  Shu-Ju Wu; Chian-Jiun Liou; Ya-Ling Chen; Shu-Chen Cheng; Wen-Chung Huang
Journal:  Cells       Date:  2021-05-25       Impact factor: 6.600

Review 9.  On a Beam of Light: Photoprotective Activities of the Marine Carotenoids Astaxanthin and Fucoxanthin in Suppression of Inflammation and Cancer.

Authors:  Elena Catanzaro; Anupam Bishayee; Carmela Fimognari
Journal:  Mar Drugs       Date:  2020-10-30       Impact factor: 5.118

Review 10.  Brown Seaweeds for the Management of Metabolic Syndrome and Associated Diseases.

Authors:  Daniela Gabbia; Sara De Martin
Journal:  Molecules       Date:  2020-09-12       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.